Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

NRM-823

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · PHASE 1 TRIAL

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

ClinicalTrials.gov

Phase 1 early-stage trial studying safety and tolerability of a novel agent; results not yet reported in this registry record.

PreliminaryNCT07182149 Normunity AccelCo Esophageal Adenocarcinoma

Reported

Planned sample size150

PhasePhase 1

Primary outcome 1Incidence of treatment-emergent adverse eve…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support